Cited by 369Childhood Cancer Survivors' Quality of LifePituitary Gland Disorders and TreatmentsCancer survivorship and care

Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study

Gurney, James G., Kadan‐Lottick, Nina S., Packer, Roger J., Neglia, Joseph P., Sklar, Charles A., Punyko, Judy A., Stovall, Marilyn, Yasui, Yutaka +5 more·2003·Cancer

Abstract

BACKGROUND: Survivors of childhood brain tumors (CBTs) are at high risk for a variety of late adverse effects. Most research on long-term effects of CBTs has been comprised of single-institution case series without comparison groups. Research on CBT late effects often is focused on neurologic and sensory outcomes, with less emphasis on other potential targets such as the endocrine and circulatory systems. The current study was conducted to contrast the incidence of endocrine and cardiovascular conditions among CBT survivors as a function of treatment and to determine the risk of occurrence of these conditions relative to a sibling comparison group. METHODS: As part of the Childhood Cancer Survivor Study (CCSS), treatment data were collected from medical records and self-reported late effects were ascertained from a survey questionnaire of 1,607 CBT patients who survived their disease for 5 or more years. For comparison purposes, questionnaire data were also collected from 3418 randomly selected siblings of participants in CCSS. RESULTS: One or more endocrine conditions were reported by 43% of CBT survivors. Compared with siblings, CBT survivors had a significantly increased risk of late-onset (>/= 5 years postdiagnosis) hypothyroidism (relative risk [RR] = 14.3; 95% confidence interval [95% CI] 9.7-21.0), growth hormone deficiency (RR = 277.8; 95% CI 111.1-694.9), the need for medications to induce puberty (RR = 86.1; 95% CI 31.1-238.2), and osteoporosis (RR = 24.7; 95% CI 9.9-61.4). One or more cardiovascular conditions were reported by 18% of CBT survivors, with an elevated late-onset risk for stroke (RR = 42.8; 95% CI 16.7-109.8), blood clots (RR = 5.7; 95% CI 3.2-10.0), and angina-like symptoms (RR = 2.0; 95% CI 1.5-2.7). Very few late effects were evident among those treated with surgery only, but risks were consistently elevated for those treated with radiation and surgery, and higher still for those who also received adjuvant chemotherapy. CONCLUSIONS: Childhood brain tumor survivors are at a significantly increased risk for several adverse endocrine and cardiovascular late effects, particularly if they were treated with radiation and chemotherapy. Lifetime medical surveillance and follow-up for potential toxicities are necessary because treatment-related complications may occur many years after therapy.

Integrity signals

Registry

Crossref · 10.1002/cncr.11095

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gurney, J. G., Kadan‐Lottick, N. S., Packer, R. J., Neglia, J. P., Sklar, C. A., Punyko, J. A., Stovall, M., Yasui, Y., Nicholson, H. S., Wolden, S., McNeil, D. E., Mertens, A. C., & Robison, L. L.
Affiliations
  • University of Minnesota (US)
  • Children's National (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • Fred Hutch Cancer Center (US)
  • Oregon Health & Science University (US)
  • National Institutes of Health (US)
Corresponding author
Gurney, James G.
Venue
Cancer
Publisher
Wiley
Published
2003-01-17
Volume
97
Issue
3
Pages
663-673
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1494071096
Cited by
369
References
22
Citations by year
2026: 9 · 2025: 5 · 2024: 7 · 2023: 7 · 2022: 12 · 2021: 15 · 2020: 13 · 2019: 13 · 2018: 18 · 2017: 22 · 2016: 21 · 2015: 24 · 2014: 21 · 2013: 15 · 2012: 18
FWCI
13.76
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (U24-CA-55727, U24CA055727)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
childhood brain tumor survivors, late effects of cancer treatment, endocrine late effects, cardiovascular late effects, hypothyroidism, growth hormone deficiency, puberty induction, osteoporosis, stroke, blood clots, radiotherapy, adjuvant chemotherapy, Childhood Cancer Survivor Study, sibling comparison, long-term cancer survivorship, treatment-related morbidity
MeSH terms
Adult, Antineoplastic Agents, Brain Neoplasms, Cardiovascular Diseases, Child, Endocrine System Diseases, Humans, Radiotherapy, Risk, Survivors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review